Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review.
Joana GoricaMaria Silvia De FeoFerdinando CoricaMarko Magdi Abdou SidrakMiriam ConteLuca FilippiOrazio SchillaciGiuseppe De VincentisViviana FrantellizziPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
The development of new radionuclides and radiopharmaceuticals targeting CCR4 show promising results in the theranostics of CCR4 sensible tumors. Although to widen its use in clinical practice, further translation of preclinical to clinical data is needed.